Szerző: " Ricci F."

Miles D.; Ciruelos E.; Schneeweiss A.; Puglisi F.; Peretz-Yablonski T.; Campone M.; Bondarenko I.; Nowecki Z.; Errihani H.; Paluch-Shimon S.; Wardley A.; Merot J.-L.; Trask P.; du Toit Y.; Pena-Murillo C.; Revelant V.; Klingbiel D.; Bachelot T.; Bouzid K.; Desmoulins I.; Coudert B.; Glogowska I.; Ciruelos Gil E.; Dalenc F.; Ricci F.; Dieras V.; Kaufman B.; Ferreira A.; Mano M.; Kalofonos H.; Hitre Erika; Láng István; Horváth Zsolt; Bodoky György; Kahán Zsuzsanna; Kollaborációs szervezet: PERUSE investigators; et al.: Final results from the PERUSE study of first-line pertuzumab plus trastuzumab plus a taxane for HER2-positive locally recurrent or metastatic breast cancer, with a multivariable approach to guide prognostication.
ANNALS OF ONCOLOGY, 32 (10). pp. 1245-1255. ISSN 0923-7534 (2021)

Ricci F.; Carrassa L.; Christodoulou M. S.; Passarella D.; Michel B.; Hunyadi Attila; Botta B.; Kavetsou E.; Detsi A.; Majer Zsuzsanna (Deckerné); Hudecz Ferenc; Bősze Szilvia; Kaminska B.; Hansen T. V.; Bertrand P.: A high-throughput screening of a chemical compound library in ovarian cancer stem cells.
COMBINATORIAL CHEMISTRY & HIGH THROUGHPUT SCREENING, 21 (1). pp. 50-56. ISSN 1386-2073 (2018)